News archive search

Search the Newsreel

Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.

Showing
109–144
Matches
1419
Sources here
24
Companies here
25
Search results Stored financial headlines

Active search

1419 matching headlines

Ticker or company: ESIMain company stories
Clear

Search results

Matching headlines

External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.

AQR Capital discloses 5.1% Phreesia (PHR) ownership in new Schedule 13G

AQR Capital Management, LLC and AQR Capital Management Holdings, LLC have reported a beneficial ownership of 5.1% in Phreesia, Inc. (PHR) through a new Schedule 13G filing. This amounts to 3,151,453 shares of common stock, with both entities sharing voting and dispositive power. The …

PHR main company
Sharemaestro market context Price above Trend Line 52 weeks -58.7% PHR stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Resideo Appoints Shane Harrison as Chief Financial Officer

Resideo Technologies has announced the appointment of Shane Harrison as its new Chief Financial Officer, effective September 1, 2026. Harrison brings over 25 years of experience in corporate finance, investor relations, and strategic transactions, having previously held CFO and senior finance roles at NRC …

REZI main company
Sharemaestro market context Price below Trend Line 52 weeks -13.4% REZI stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Can SNPS Leverage AI to Accelerate Chip Design and Drive Growth?

Synopsys SNPS is benefiting from the large AI infrastructure expansion, which is fueling semiconductor R&D, system-level design activity and demand for advanced AI computing capabilities. The company is integrating AI throughout its product portfolio to automate engineering processes, accelerate design cycles and enhance customer …

CDNS main company C1DN34 main company CDNS main company CDNS main company
Sharemaestro market context Trend signal active 52 weeks -14.3% CDNS stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Resideo earnings spotlight: First test as building tech pure-play

Resideo Technologies Inc. is set to report its second-quarter earnings, marking its first results as a pure-play building technologies company after spinning off ADI Global Distribution. Analysts anticipate earnings of $0.66 per share on $1.93 billion in revenue, with investors closely watching gross margin …

REZI main company
Sharemaestro market context Price below Trend Line 52 weeks -13.4% REZI stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Is NexPoint Residential Trust (NXRT) Stock Undervalued Right Now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks. Considering these trends, …

NXRT main company
Sharemaestro market context Price below Trend Line 52 weeks -21.4% NXRT stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Design Therapeutics, Inc. $DSGN Shares Bought by Dimensional Fund Advisors LP

Dimensional Fund Advisors LP significantly increased its stake in Design Therapeutics (NASDAQ:DSGN) by 45.0% in Q1, now owning 431,840 shares valued at $4.59 million. Other institutional investors also adjusted their holdings in the company. Design Therapeutics reported better-than-expected Q2 earnings and has an average …

DSGN main company
Sharemaestro market context Trend signal active 52 weeks +181.9% · Next-week setup positive 55.7% DSGN stored weekly price path from 22 Aug 2025 to 14 Aug 2026

(NXRT) Price Dynamics and Execution-Aware Positioning

This article analyzes Nexpoint Residential Trust Inc. (NASDAQ: NXRT) revealing a near-term neutral sentiment amidst mid and long-term weakness, driven by a mid-channel oscillation pattern. It highlights an exceptional 32.3:1 risk-reward setup targeting a 9.5% gain versus 0.3% risk. The analysis also provides specific …

NXRT main company
Sharemaestro market context Price below Trend Line 52 weeks -21.4% NXRT stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Element Solutions Inc (ESI) in Solstice merger aiming for $6.8B sales, AI infrastructure scale

Solstice Advanced Materials Inc. is planning to acquire Element Solutions Inc (ESI) to form a critical infrastructure and advanced computing focused materials company. The combined entity is projected to achieve $6.8 billion in revenue with 26% margins by 2025, growing to over $7 billion …

ESI main company
Sharemaestro market context Trend signal active 52 weeks +51.4% ESI stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Cadence Design Systems Inc. stock outperforms competitors despite losses on the day

Cadence Design Systems Inc. (CDNS) saw its stock decline by 1.32% to $327.53 on Tuesday, marking its second consecutive day of losses. This occurred despite a generally negative market, with the S&P 500 Index and Dow Jones Industrial Average also experiencing drops. The article …

CDNS main company
Sharemaestro market context Trend signal active 52 weeks -7.1% CDNS stored weekly price path from 22 Aug 2025 to 14 Aug 2026

If You Invested $1000 In Element Solutions Stock 10 Years Ago, You Would Have This Much Today

Element Solutions (NYSE: ESI) has significantly outperformed the market over the last decade, achieving an average annual return of 15.44%. An initial investment of $1000 in ESI stock ten years ago would now be worth $4,194.26, demonstrating the substantial impact of compounded returns over …

ESI main company
Sharemaestro market context Trend signal active 52 weeks +51.4% ESI stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Bronstein, Gewirtz & Grossman, LLC Is Investigating Phreesia, Inc. (PHR) And Encourages Shareholders to Connect

Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Phreesia, Inc. (NYSE: PHR) securities who bought prior to March 30, 2026, and still hold their shares. The investigation focuses on whether Phreesia and its officers/directors engaged in corporate wrongdoing. …

PHR main company
Sharemaestro market context Price above Trend Line 52 weeks -58.7% PHR stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Design Therapeutics, Inc. (NASDAQ:DSGN) Given Average Rating of "Moderate Buy" by Brokerages

Design Therapeutics, Inc. (NASDAQ:DSGN) has received a "Moderate Buy" consensus rating from eight brokerages, with an average 12-month price target of $16.50. The stock recently opened at $14.33, trading above its 50-day and 200-day moving averages, and institutional investors own over 56% of the …

DSGN main company
Sharemaestro market context Trend signal active 52 weeks +181.9% · Next-week setup positive 55.7% DSGN stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Offshore Pipelines and Marine Transport: Genesis Energy at Citi

Genesis Energy, L.P. (NYSE: GEL) announced it will host investor meetings at Citi's 2026 Natural Resources Conference in Las Vegas, Nevada on August 11, 2026. The company, a diversified midstream energy master limited partnership, will provide its latest investor presentation on its website. Genesis …

GEL main company
Sharemaestro market context Price below Trend Line 52 weeks -4.6% · Next-week setup positive 61.1% GEL stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Genesis Energy, L.P. to Participate in Citi’s 2026 Natural Resources Conference

Genesis Energy, L.P. announced its participation in Citi’s 2026 Natural Resources Conference in Las Vegas, Nevada, on August 11, 2026. The company, a diversified midstream energy master limited partnership, will host investor meetings and its latest investor presentation is available online.

GEL main company
Sharemaestro market context Price below Trend Line 52 weeks -4.6% · Next-week setup positive 61.1% GEL stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Find financial news

Search the Newsreel

Use one field or combine several. Results are newest first.

Evidence context